3rd Quarter - Termination

VARIAN MEDICAL SYSTEMS, INC. for VARIAN MEDICAL SYSTEMS, INC.

Period 3rd Quarter 2023 Filed Oct 20, 2023 Signed by Kat Cantu, Chief of Staff, Govt. Affairs

Official filing
Firm
VARIAN MEDICAL SYSTEMS, INC.
Client
VARIAN MEDICAL SYSTEMS, INC.
Income
—
Expenses
$260,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Sep 30, 2023

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to FDA guidance of Remanufacturing Medical Devices; Issues related to Right to Repair; Issued related to Artificial Intelligence; H.R.2369 - Verifying Accurate, Leading-edge IVCT Development (VALID) Act; Physician Fee Schedule/Reimbursement Issues; Issues related to price transparency.

LobbyistCovered position, as disclosed
ANDREW WHITMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2369 (118th)

Medical/Disease Research/Clinical Labs MED

H.R. 1199 / S. 1544 - Facilitating Innovative Nuclear Diagnostics Act (FIND Act); Physician Fee Schedule / Reimbursement issues; Artificial Intelligence for Medical Devices, including issues related to Medicare reimbursement; H.R.2369 - Verifying Accurate, Leading-edge IVCT Development (VALID) Act; and Issues related to Transitional Coverage for Emerging Technologies.

LobbyistCovered position, as disclosed
ANDREW WHITMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1544 (118th), H.R. 1199 (118th), H.R. 2369 (118th)

Education EDU

Issues related to workforce development of allied healthcare professionals.

LobbyistCovered position, as disclosed
ANDREW WHITMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Labor Issues/Antitrust/Workplace LBR

Issues related to workforce development of allied healthcare professionals.

LobbyistCovered position, as disclosed
ANDREW WHITMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Site neutral payment policy H.R. 1199 / S. 1544 - Facilitating Innovative Nuclear Diagnostics Act (FIND Act); H.R. 1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023; Artificial Intelligence for Medical Devices, including issues related to Medicare reimbursement; and Issues related to price transparency.

LobbyistCovered position, as disclosed
ANDREW WHITMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1691 (118th), H.R. 1199 (118th), S. 1544 (118th)

Trade (domestic/foreign) TRD

Site neutral payment policy; and Issues related to export controls and Russian sanctions.

LobbyistCovered position, as disclosed
ANDREW WHITMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.